Navigation Links

Company Stryker Corporation
Item Revolution™
  • Reduced mix time.
  • Fast, convenient setup
  • Powered mixing for consistent results.
  • Consistent, quality mix every time.
  • Clear cartridge for unsurpassed visibility.
  • Minimal wasted cement.
  • Ideal blade design mixes all cements thoroughly.
  • Up to 3 batch capacity for any application.
  • Two-speed injection gun.
  • Description Revolution™ represents the latest in advanced cartridge mixing and delivery systems. This simple, universal mixer quickly mixes and mechanically injects all types of bone cement safely and conveniently.

    The Revolution&trade line-up includes a large selection of nozzles for accurate placement of cement, even in difficult to access areas. A new, anatomically correct femoral pressurizer design ensures maximum cement intrusion into bone interstices.
    Info Stryker Corporation
    Customer Service: (269) 385-2600
    Web site:

    Related medicine products :

    1. Simplex™ P Bone Cement with Tobramycin
    2. The APR Hip Family - CoCr Cemented
    3. The Foundation 450 Series Cemented Stem
    4. The Foundation 460 Series Cemented Stem
    5. Stability Cemented Stem
    6. Performa Cemented Stem
    7. Implex Cemented Hip Stems
    8. The Progeny Hip System - Progeny Cemented Standard Stem
    9. OSCAR Ultrasonic Bone Cement Remover
    10. Palacos Bone Cement
    11. Palacos® G Bone Cement with Gentamicin
    ... are rigid endoscopes for general applications and are ... diameters of borescopes, i.e. rigid endoscopes, range between ... from 0 up to a 120 retrospection, and ... wide angle view. Endoscopes with working lengths of ...
    Patented* Design for Endoscopic Shunt Placement. Designed to pass through standard shunt ventricular catheters for optically guided placement....
    Preclude Dura Substitute is the only non-biological membrane designed to "seal" around suture holes. 0.3 mm as nominal thickness....
    ... is a new biological material ... pure collagen implant, lyoplant can ... months, replacing implant material with ... natural structure minimizes suture channels, ...
    Medicine Products:
    (Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
    (Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
    (Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
    (Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
    (Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
    Breaking Medicine News(10 mins):
    (Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
    (Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
    (Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
    Breaking Medicine Technology: